Coronary suite
Transforming complex PCI procedures into confident cardiac care
Philips coronary artery disease (CAD) solutions consist of advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services, working together to efficiently support every step of coronary procedures. From diagnosis to restoring vessel patency, the coronary suite ecosystem is designed to enhance performance and efficiency today while serving as your launching pad to the future and keeping you close to the heart of CAD.
Improving cath lab performance while staying close to the heart
Enabling technologies for Coronary suite
ClarityIQ technology delivers significantly lower dose across the clinical area, patients, and operators.
The Philips IntraSight Interventional Applications Platform is built for today's cath lab. Offers imaging and physiology tools with iFR, IVUS ...
Learn how you can guide PCI by using iFR index with coronary physiology for measuring pressure in diagnostic & interventional procedures.
FlexArm ceiling-mounted system provides unlimited imaging flexibility for diverse procedures and exceptional positioning freedom for medical teams.
Related procedures
Advance percutaneous coronary interventions with imaging solutions, IVUS and real-time fluoroscopy for precise diagnosis and treatment.
Explore the different challenges seen in complex percutaneous coronary intervention (PCI) cases and how Philips’ specialty tools can help.
- Coronary IVUS Technologies Intravascular imaging improves outcomes and reduces death Stone G, et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Published Online February 21, 2024
- Philips whitepaper 12nc 4522 991 30501;Reduction of procedure time by 17% with Philips Azurion in independently verified study; Philips Azurion Lab Performance Study. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
- Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4 Contrast trial www.documents.philips.com/assets/20240219/0e2a77c4a6904c6eaae3b11b00df6861.pdf
- Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017.
- Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017.
- Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
- A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503.
- Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC: Cardiovascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227.
- Co-registration tools available within IntraSight 7 configuration via SyncVision